B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy-Reference-Cited by-同舟云学术

B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy

Published:2021-01 Issue: Volume:183 Page:114298
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Cheng Nan,Bei Yuncheng,Song Yue,Zhang Weijie,Xu Lizhi,Zhang Wenlong,Yang Nanfei,Bai Xuexia,Shu Yuxin,Shen Pingping

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference46 articles.

1. Breast cancer;Harbeck;Nat. Rev. Dis. Primers,2019

2. Targeted Therapies For Triple-Negative Breast Cancer: Combating A Stubborn Disease;Kalimutho;Trends Pharmacol. Sci.,2015

3. Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance;Yu;Chin. J. Cancer Res.,2017

4. High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis;Yuan;Oncol. Targets Ther.,2014

5. Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of prometastatic tumor-associated macrophages;Frankenberger;Cancer Res.,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review);International Journal of Oncology;2024-09-05

2. CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression;Blood Advances;2024-08-16

3. A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation;Biochemical Pharmacology;2024-07

4. Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature;Frontiers in Oncology;2024-06-17

5. B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors;Cancer Research Communications;2024-06-04